Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,815
archived clinical trials in
Parkinsons Disease

Effect of Lower Extremity Ankle Foot Orthoses in Parkinson's Disease
Investigation of Lower Extremity Orthoses on Gait in Persons With Parkinson's Disease: a Case Series.
Status: Enrolling
Updated:  7/6/2015
UT Southwestern Medical Center, School of Health Professions
mi
from
Dallas, TX
Effect of Lower Extremity Ankle Foot Orthoses in Parkinson's Disease
Investigation of Lower Extremity Orthoses on Gait in Persons With Parkinson's Disease: a Case Series.
Status: Enrolling
Updated: 7/6/2015
UT Southwestern Medical Center, School of Health Professions
mi
from
Dallas, TX
Click here to add this to my saved trials
Naltrexone for Impulse Control Disorders in Parkinson's Disease
Randomized, Double-blind, Placebo-controlled Study of Naltrexone for Impulse Control Disorders in Parkinson's Disease
Status: Enrolling
Updated:  7/13/2015
Univ of Pennsylvania
mi
from
Philadelphia, PA
Naltrexone for Impulse Control Disorders in Parkinson's Disease
Randomized, Double-blind, Placebo-controlled Study of Naltrexone for Impulse Control Disorders in Parkinson's Disease
Status: Enrolling
Updated: 7/13/2015
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Effects of Coenzyme Q10 in Progressive Supranuclear Palsy (PSP)
Effects of Coenzyme Q10 in Progressive Supranuclear Palsy (PSP): A Multicenter, Randomized, Placebo-controlled, Double Blind Study
Status: Enrolling
Updated:  8/4/2015
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Effects of Coenzyme Q10 in Progressive Supranuclear Palsy (PSP)
Effects of Coenzyme Q10 in Progressive Supranuclear Palsy (PSP): A Multicenter, Randomized, Placebo-controlled, Double Blind Study
Status: Enrolling
Updated: 8/4/2015
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Effects of Coenzyme Q10 in Progressive Supranuclear Palsy (PSP)
Effects of Coenzyme Q10 in Progressive Supranuclear Palsy (PSP): A Multicenter, Randomized, Placebo-controlled, Double Blind Study
Status: Enrolling
Updated:  8/4/2015
Lahey Clinic
mi
from
Burlington, MA
Effects of Coenzyme Q10 in Progressive Supranuclear Palsy (PSP)
Effects of Coenzyme Q10 in Progressive Supranuclear Palsy (PSP): A Multicenter, Randomized, Placebo-controlled, Double Blind Study
Status: Enrolling
Updated: 8/4/2015
Lahey Clinic
mi
from
Burlington, MA
Click here to add this to my saved trials
Effects of Coenzyme Q10 in Progressive Supranuclear Palsy (PSP)
Effects of Coenzyme Q10 in Progressive Supranuclear Palsy (PSP): A Multicenter, Randomized, Placebo-controlled, Double Blind Study
Status: Enrolling
Updated:  8/4/2015
University of Alabama
mi
from
Birmingham, AL
Effects of Coenzyme Q10 in Progressive Supranuclear Palsy (PSP)
Effects of Coenzyme Q10 in Progressive Supranuclear Palsy (PSP): A Multicenter, Randomized, Placebo-controlled, Double Blind Study
Status: Enrolling
Updated: 8/4/2015
University of Alabama
mi
from
Birmingham, AL
Click here to add this to my saved trials
Acupuncture for Fatigue in Parkinson's Disease
Acupuncture as a Symptomatic Treatment for Fatigue in Parkinson's Disease
Status: Enrolling
Updated:  8/10/2015
University of Colorado Denver
mi
from
Aurora, CO
Acupuncture for Fatigue in Parkinson's Disease
Acupuncture as a Symptomatic Treatment for Fatigue in Parkinson's Disease
Status: Enrolling
Updated: 8/10/2015
University of Colorado Denver
mi
from
Aurora, CO
Click here to add this to my saved trials
BradyXplore Phase II: Bradykinesia Feature Extraction System
BradyXplore Phase II: Bradykinesia Feature Extraction System
Status: Enrolling
Updated:  8/10/2015
University of Cincinnati
mi
from
Cincinnati, OH
BradyXplore Phase II: Bradykinesia Feature Extraction System
BradyXplore Phase II: Bradykinesia Feature Extraction System
Status: Enrolling
Updated: 8/10/2015
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
BradyXplore Phase II: Bradykinesia Feature Extraction System
BradyXplore Phase II: Bradykinesia Feature Extraction System
Status: Enrolling
Updated:  8/10/2015
Cleveland Clinic
mi
from
Cleveland, OH
BradyXplore Phase II: Bradykinesia Feature Extraction System
BradyXplore Phase II: Bradykinesia Feature Extraction System
Status: Enrolling
Updated: 8/10/2015
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Phase 2A Study of GM 608 in Mild to Moderate Parkinson Disease
GM 608 in A Phase IIA Pilot Double-blinded, Randomized, Placebo Controlled Trial in Mild to Moderate Parkinson Disease
Status: Enrolling
Updated:  8/17/2015
Columbia University Medical Center/NY Presbyterian Hospital
mi
from
New York, NY
Phase 2A Study of GM 608 in Mild to Moderate Parkinson Disease
GM 608 in A Phase IIA Pilot Double-blinded, Randomized, Placebo Controlled Trial in Mild to Moderate Parkinson Disease
Status: Enrolling
Updated: 8/17/2015
Columbia University Medical Center/NY Presbyterian Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Effects of Aerobic Exercise in Parkinson's Disease
Effects of Aerobic Exercise in Parkinson's Disease
Status: Enrolling
Updated:  8/25/2015
VA Medical Center, Iowa City
mi
from
Iowa City, IA
Effects of Aerobic Exercise in Parkinson's Disease
Effects of Aerobic Exercise in Parkinson's Disease
Status: Enrolling
Updated: 8/25/2015
VA Medical Center, Iowa City
mi
from
Iowa City, IA
Click here to add this to my saved trials
Cognitive Rehabilitation in Parkinson's Disease
PC-based Rehabilitation of Motor Planning Deficits in Parkinson Disease
Status: Enrolling
Updated:  8/28/2015
Overton Brooks VA Medical Center, Shreveport, LA
mi
from
Shreveport, LA
Cognitive Rehabilitation in Parkinson's Disease
PC-based Rehabilitation of Motor Planning Deficits in Parkinson Disease
Status: Enrolling
Updated: 8/28/2015
Overton Brooks VA Medical Center, Shreveport, LA
mi
from
Shreveport, LA
Click here to add this to my saved trials
The Effect of Rifampin on the Metabolism of Istradefylline in Healthy Volunteers.
Effect of a Strong Enzyme Inducer, Rifampin, on the Single-Dose Pharmacokinetics of Istradefylline in Healthy Subjects
Status: Enrolling
Updated:  9/2/2015
Celerion
mi
from
Tempe, AZ
The Effect of Rifampin on the Metabolism of Istradefylline in Healthy Volunteers.
Effect of a Strong Enzyme Inducer, Rifampin, on the Single-Dose Pharmacokinetics of Istradefylline in Healthy Subjects
Status: Enrolling
Updated: 9/2/2015
Celerion
mi
from
Tempe, AZ
Click here to add this to my saved trials
Parkinson's Disease Genetics Database
Parkinson's Disease Genetics Database
Status: Enrolling
Updated:  9/15/2015
The Feinstein Institute for Medical Research
mi
from
Manhasset, NY
Parkinson's Disease Genetics Database
Parkinson's Disease Genetics Database
Status: Enrolling
Updated: 9/15/2015
The Feinstein Institute for Medical Research
mi
from
Manhasset, NY
Click here to add this to my saved trials
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated:  9/15/2015
Univeristy of Alabama at Birmingham
mi
from
Birmingham, AL
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated: 9/15/2015
Univeristy of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated:  9/15/2015
Barrow Neurological Institute
mi
from
Phoenix, AZ
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated: 9/15/2015
Barrow Neurological Institute
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated:  9/15/2015
The Parkinson's & Movement Disorder Institute
mi
from
Fountain Valley, CA
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated: 9/15/2015
The Parkinson's & Movement Disorder Institute
mi
from
Fountain Valley, CA
Click here to add this to my saved trials
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated:  9/15/2015
University of Southern California
mi
from
Los Angeles, CA
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated: 9/15/2015
University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated:  9/15/2015
University of California San Fransisco
mi
from
San Fransisco, CA
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated: 9/15/2015
University of California San Fransisco
mi
from
San Fransisco, CA
Click here to add this to my saved trials
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated:  9/15/2015
Univeristy of Colorado Denver
mi
from
Aurora, CO
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated: 9/15/2015
Univeristy of Colorado Denver
mi
from
Aurora, CO
Click here to add this to my saved trials
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated:  9/15/2015
University of Florida - Jacksonville
mi
from
Jacksonville, FL
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated: 9/15/2015
University of Florida - Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated:  9/15/2015
University of Miami
mi
from
Miami, FL
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated: 9/15/2015
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated:  9/15/2015
University of South Florida
mi
from
Tampa, FL
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated: 9/15/2015
University of South Florida
mi
from
Tampa, FL
Click here to add this to my saved trials
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated:  9/15/2015
Emory University School of Medicine
mi
from
Atlanta, GA
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated: 9/15/2015
Emory University School of Medicine
mi
from
Atlanta, GA
Click here to add this to my saved trials
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated:  9/15/2015
Pacific Health Research & Education Institute
mi
from
Honolulu, HI
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated: 9/15/2015
Pacific Health Research & Education Institute
mi
from
Honolulu, HI
Click here to add this to my saved trials
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated:  9/15/2015
Rush University Medical Center
mi
from
Chicago, IL
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated: 9/15/2015
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated:  9/15/2015
University of Kansas Medical Center
mi
from
Kansas City, KA
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated: 9/15/2015
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated:  9/15/2015
University of Kentucky
mi
from
Lexington, KY
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated: 9/15/2015
University of Kentucky
mi
from
Lexington, KY
Click here to add this to my saved trials
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated:  9/15/2015
LSU Health Science Center Shreveport
mi
from
Shreveport, LA
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated: 9/15/2015
LSU Health Science Center Shreveport
mi
from
Shreveport, LA
Click here to add this to my saved trials
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated:  9/15/2015
Johns Hopkins University
mi
from
Baltimore, MD
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated: 9/15/2015
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated:  9/15/2015
Brigham and Women's Hosp
mi
from
Boston, MA
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated: 9/15/2015
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated:  9/15/2015
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated: 9/15/2015
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated:  9/15/2015
University of Michigan
mi
from
Ann Arbor, MI
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated: 9/15/2015
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated:  9/15/2015
Michigan State University
mi
from
East Lansing, MI
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated: 9/15/2015
Michigan State University
mi
from
East Lansing, MI
Click here to add this to my saved trials
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated:  9/15/2015
Struthers Parkinson's Center
mi
from
Golden Valley, MN
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated: 9/15/2015
Struthers Parkinson's Center
mi
from
Golden Valley, MN
Click here to add this to my saved trials
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated:  9/15/2015
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated: 9/15/2015
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated:  9/15/2015
SUNY Downstate Medical Center
mi
from
Brooklyn, NY
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated: 9/15/2015
SUNY Downstate Medical Center
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated:  9/15/2015
North Shore-LIJ Health System
mi
from
Manhasset, NY
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated: 9/15/2015
North Shore-LIJ Health System
mi
from
Manhasset, NY
Click here to add this to my saved trials
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated:  9/15/2015
Duke University
mi
from
Durham, NC
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated: 9/15/2015
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated:  9/15/2015
Oregon Health and Science University
mi
from
Portland, OR
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated: 9/15/2015
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated:  9/15/2015
Univ of Pennsylvania
mi
from
Philadelphia, PA
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated: 9/15/2015
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated:  9/15/2015
Thomas Jefferson University
mi
from
Philadelphia, PA
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated: 9/15/2015
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated:  9/15/2015
Medical University of South Carolina
mi
from
Charleston, SC
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated: 9/15/2015
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated:  9/15/2015
Vanderbilt University
mi
from
Nashville, TN
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated: 9/15/2015
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated:  9/15/2015
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated: 9/15/2015
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated:  9/15/2015
University of Vermont
mi
from
Burlington, VT
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated: 9/15/2015
University of Vermont
mi
from
Burlington, VT
Click here to add this to my saved trials
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated:  9/15/2015
University of Virginia
mi
from
Charlottesville, VA
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated: 9/15/2015
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated:  9/15/2015
University of Florida
mi
from
Gainsville, FL
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated: 9/15/2015
University of Florida
mi
from
Gainsville, FL
Click here to add this to my saved trials
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated:  9/15/2015
Medical College of Georgia
mi
from
Augusta, GA
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated: 9/15/2015
Medical College of Georgia
mi
from
Augusta, GA
Click here to add this to my saved trials
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated:  9/15/2015
Northwestern University
mi
from
Chicago, IL
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated: 9/15/2015
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated:  9/15/2015
Ochsner Clinic Foundation
mi
from
New Orleans, LA
Pioglitazone in Early Parkinson's Disease
A Multi-Center, Double-Blind, Placebo-Controlled Phase II Study of Pioglitazone in Early Parkinson's Disease
Status: Enrolling
Updated: 9/15/2015
Ochsner Clinic Foundation
mi
from
New Orleans, LA
Click here to add this to my saved trials